| Application no. and date | 07118593.8 (espacenet) (Federated) (European Patent Register), 20010212 | | Patent/reg. no. and date | DK/EP 1873148, 20091118 | | Publication date | 20080102 | | Priority no. and date | GB 0003305, 20000215 | | EP pub. no. and date |
EP 1873148 20080102 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE,
SHIONOGI & CO., LTD., 1-8, Doshomachi 3-chome,
Chuo-ku
Osaka 541-0045, JP | | Applicant ref. no. | AST Z70666-2X | | Inventor | Taylor, Nigel Philip, AstraZeneca
Charter Way
Macclesfield, SK10 2NA, GB,
Okada, Tetsuo, Shionogi & Co Ltd
12-4 Sagisu 5-chome
Fakushima-ku
Osaka 553-002, JP | | Representative | | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 3/06 (2006.01) , C07D 239/42 (2006.01) | | Title | Farmaceutiske sammensætninger, der indeholder krystallinske salte af 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-ensyre | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
